Article
A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry
7 Mar 2021
Abstract excerpt
Colorectal cancer (CRC) is a heterogeneous disease with different genetic and molecular backgrounds, leading to a diverse patient prognosis and treatment response. Four consensus molecular subtypes (CMS 1–4) have recently been proposed based on transcriptome profiling. A clinically practical immunohistochemistry (IHC) based CMS classifier consisting of the four markers FRMD6, ZEB1 , HTR2B, and CDX2 was then...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
